A study by Rasheed et al. demonstrated that ART treatment in non-small-cell lung cancer (NSCLC) cell lines inhibited the expression of MMP-2, MMP-7, and u-PA, leading to the inhibition of metastasis and invasion. The gene discussed is MMP2; the disease is non-small cell lung carcinoma.